120 related articles for article (PubMed ID: 21252144)
1. Lipoprotein(a) genetic variants associated with coronary and peripheral vascular disease but not with stroke risk in the Heart Protection Study.
Hopewell JC; Clarke R; Parish S; Armitage J; Lathrop M; Hager J; Collins R;
Circ Cardiovasc Genet; 2011 Feb; 4(1):68-73. PubMed ID: 21252144
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
Clarke R; Peden JF; Hopewell JC; Kyriakou T; Goel A; Heath SC; Parish S; Barlera S; Franzosi MG; Rust S; Bennett D; Silveira A; Malarstig A; Green FR; Lathrop M; Gigante B; Leander K; de Faire U; Seedorf U; Hamsten A; Collins R; Watkins H; Farrall M;
N Engl J Med; 2009 Dec; 361(26):2518-28. PubMed ID: 20032323
[TBL] [Abstract][Full Text] [Related]
3. Association of LPA Variants With Aortic Stenosis: A Large-Scale Study Using Diagnostic and Procedural Codes From Electronic Health Records.
Chen HY; Dufresne L; Burr H; Ambikkumar A; Yasui N; Luk K; Ranatunga DK; Whitmer RA; Lathrop M; Engert JC; Thanassoulis G
JAMA Cardiol; 2018 Jan; 3(1):18-23. PubMed ID: 29128868
[TBL] [Abstract][Full Text] [Related]
4. Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study.
Zewinger S; Kleber ME; Tragante V; McCubrey RO; Schmidt AF; Direk K; Laufs U; Werner C; Koenig W; Rothenbacher D; Mons U; Breitling LP; Brenner H; Jennings RT; Petrakis I; Triem S; Klug M; Filips A; Blankenberg S; Waldeyer C; Sinning C; Schnabel RB; Lackner KJ; Vlachopoulou E; Nygård O; Svingen GFT; Pedersen ER; Tell GS; Sinisalo J; Nieminen MS; Laaksonen R; Trompet S; Smit RAJ; Sattar N; Jukema JW; Groesdonk HV; Delgado G; Stojakovic T; Pilbrow AP; Cameron VA; Richards AM; Doughty RN; Gong Y; Cooper-DeHoff R; Johnson J; Scholz M; Beutner F; Thiery J; Smith JG; Vilmundarson RO; McPherson R; Stewart AFR; Cresci S; Lenzini PA; Spertus JA; Olivieri O; Girelli D; Martinelli NI; Leiherer A; Saely CH; Drexel H; Mündlein A; Braund PS; Nelson CP; Samani NJ; Kofink D; Hoefer IE; Pasterkamp G; Quyyumi AA; Ko YA; Hartiala JA; Allayee H; Tang WHW; Hazen SL; Eriksson N; Held C; Hagström E; Wallentin L; Åkerblom A; Siegbahn A; Karp I; Labos C; Pilote L; Engert JC; Brophy JM; Thanassoulis G; Bogaty P; Szczeklik W; Kaczor M; Sanak M; Virani SS; Ballantyne CM; Lee VV; Boerwinkle E; Holmes MV; Horne BD; Hingorani A; Asselbergs FW; Patel RS; ; Krämer BK; Scharnagl H; Fliser D; März W; Speer T
Lancet Diabetes Endocrinol; 2017 Jul; 5(7):534-543. PubMed ID: 28566218
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between lipoprotein(a) genetic variants and subsequent cardiovascular events in Chinese Han patients with coronary artery disease after percutaneous coronary intervention.
Li ZG; Li G; Zhou YL; Chen ZJ; Yang JQ; Zhang Y; Sun S; Zhong SL
Lipids Health Dis; 2013 Aug; 12():127. PubMed ID: 23978127
[TBL] [Abstract][Full Text] [Related]
6. Coronary artery disease and the risk-associated LPA variants, rs3798220 and rs10455872, in patients with suspected familial hypercholesterolaemia.
Page MM; Ellis KL; Pang J; Chan DC; Hooper AJ; Bell DA; Burnett JR; Watts GF
Clin Chim Acta; 2020 Nov; 510():211-215. PubMed ID: 32681934
[TBL] [Abstract][Full Text] [Related]
7. Investigation of LPA sequence variants rs6415084, rs3798220 with conventional coronary artery disease in Iranian CAD patients.
Rouhani B; Ghaderian SMH; Salehi Z
Hum Antibodies; 2019; 27(2):99-104. PubMed ID: 30594920
[TBL] [Abstract][Full Text] [Related]
8. Association between lipoprotein(a) (Lp(a)) levels and Lp(a) genetic variants with coronary artery calcification.
Pechlivanis S; Mahabadi AA; Hoffmann P; Nöthen MM; Broecker-Preuss M; Erbel R; Moebus S; Stang A; Jöckel KH
BMC Med Genet; 2020 Mar; 21(1):62. PubMed ID: 32220223
[TBL] [Abstract][Full Text] [Related]
9. LPA rs10455872 polymorphism is associated with coronary lesions in Brazilian patients submitted to coronary angiography.
Santos PC; Bueno CT; Lemos PA; Krieger JE; Pereira AC
Lipids Health Dis; 2014 Apr; 13():74. PubMed ID: 24776095
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism.
Helgadottir A; Gretarsdottir S; Thorleifsson G; Holm H; Patel RS; Gudnason T; Jones GT; van Rij AM; Eapen DJ; Baas AF; Tregouet DA; Morange PE; Emmerich J; Lindblad B; Gottsäter A; Kiemeny LA; Lindholt JS; Sakalihasan N; Ferrell RE; Carey DJ; Elmore JR; Tsao PS; Grarup N; Jørgensen T; Witte DR; Hansen T; Pedersen O; Pola R; Gaetani E; Magnadottir HB; Wijmenga C; Tromp G; Ronkainen A; Ruigrok YM; Blankensteijn JD; Mueller T; Wells PS; Corral J; Soria JM; Souto JC; Peden JF; Jalilzadeh S; Mayosi BM; Keavney B; Strawbridge RJ; Sabater-Lleal M; Gertow K; Baldassarre D; Nyyssönen K; Rauramaa R; Smit AJ; Mannarino E; Giral P; Tremoli E; de Faire U; Humphries SE; Hamsten A; Haraldsdottir V; Olafsson I; Magnusson MK; Samani NJ; Levey AI; Markus HS; Kostulas K; Dichgans M; Berger K; Kuhlenbäumer G; Ringelstein EB; Stoll M; Seedorf U; Rothwell PM; Powell JT; Kuivaniemi H; Onundarson PT; Valdimarsson E; Matthiasson SE; Gudbjartsson DF; Thorgeirsson G; Quyyumi AA; Watkins H; Farrall M; Thorsteinsdottir U; Stefansson K
J Am Coll Cardiol; 2012 Aug; 60(8):722-9. PubMed ID: 22898070
[TBL] [Abstract][Full Text] [Related]
11. Validation and quantification of genetic determinants of lipoprotein-a levels and predictive value for angiographic coronary artery disease.
Anderson JL; Knight S; May HT; Horne BD; Bair TL; Huntinghouse JA; Rollo JS; Muhlestein JB; Carlquist JF
Am J Cardiol; 2013 Sep; 112(6):799-804. PubMed ID: 23735648
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis.
Saleheen D; Haycock PC; Zhao W; Rasheed A; Taleb A; Imran A; Abbas S; Majeed F; Akhtar S; Qamar N; Zaman KS; Yaqoob Z; Saghir T; Rizvi SNH; Memon A; Mallick NH; Ishaq M; Rasheed SZ; Memon FU; Mahmood K; Ahmed N; Frossard P; Tsimikas S; Witztum JL; Marcovina S; Sandhu M; Rader DJ; Danesh J
Lancet Diabetes Endocrinol; 2017 Jul; 5(7):524-533. PubMed ID: 28408323
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes.
Qi Q; Workalemahu T; Zhang C; Hu FB; Qi L
Eur Heart J; 2012 Feb; 33(3):325-34. PubMed ID: 21900290
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic Characterization of Genetically Lowered Human Lipoprotein(a) Levels.
Emdin CA; Khera AV; Natarajan P; Klarin D; Won HH; Peloso GM; Stitziel NO; Nomura A; Zekavat SM; Bick AG; Gupta N; Asselta R; Duga S; Merlini PA; Correa A; Kessler T; Wilson JG; Bown MJ; Hall AS; Braund PS; Samani NJ; Schunkert H; Marrugat J; Elosua R; McPherson R; Farrall M; Watkins H; Willer C; Abecasis GR; Felix JF; Vasan RS; Lander E; Rader DJ; Danesh J; Ardissino D; Gabriel S; Saleheen D; Kathiresan S; ;
J Am Coll Cardiol; 2016 Dec; 68(25):2761-2772. PubMed ID: 28007139
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein(a) plasma levels are not associated with incident microvascular complications in type 2 diabetes mellitus.
Singh SS; Rashid M; Lieverse AG; Kronenberg F; Lamina C; Mulder MT; de Rijke YB; Sijbrands EJG; van Hoek M
Diabetologia; 2020 Jun; 63(6):1248-1257. PubMed ID: 32152647
[TBL] [Abstract][Full Text] [Related]
16. Single variants can explain the association between coronary heart disease and haplotypes in the apolipoprotein(a) locus.
Shiffman D; Louie JZ; Rowland CM; Malloy MJ; Kane JP; Devlin JJ
Atherosclerosis; 2010 Sep; 212(1):193-6. PubMed ID: 20605575
[TBL] [Abstract][Full Text] [Related]
17. The LPA gene C93T polymorphism influences plasma lipoprotein(a) levels and is independently associated with susceptibility to peripheral arterial disease.
Catalano M; Cortelazzo A; Yilmaz Y; Perilli E; Carzaniga G; Emanuele E
Clin Chim Acta; 2008 Jan; 387(1-2):109-12. PubMed ID: 17942087
[TBL] [Abstract][Full Text] [Related]
18. Elevated lipoprotein(a) and genetic polymorphisms in the LPA gene may predict cardiovascular events.
Gu JX; Huang J; Li SS; Zhou LH; Yang M; Li Y; Zhang AM; Yin Y; Zhang N; Jia M; Su M
Sci Rep; 2022 Mar; 12(1):3588. PubMed ID: 35246583
[TBL] [Abstract][Full Text] [Related]
19. Effects of the coronary artery disease associated LPA and 9p21 loci on risk of aortic valve stenosis.
Trenkwalder T; Nelson CP; Musameh MD; Mordi IR; Kessler T; Pellegrini C; Debiec R; Rheude T; Lazovic V; Zeng L; Martinsson A; Gustav Smith J; Gådin JR; Franco-Cereceda A; Eriksson P; Nielsen JB; Graham SE; Willer CJ; Hveem K; Kastrati A; Braund PS; Palmer CNA; Aracil A; Husser O; Koenig W; Schunkert H; Lang CC; Hengstenberg C; Samani NJ
Int J Cardiol; 2019 Feb; 276():212-217. PubMed ID: 30482443
[TBL] [Abstract][Full Text] [Related]
20. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
Pérez de Isla L; Alonso R; Mata N; Saltijeral A; Muñiz O; Rubio-Marin P; Diaz-Diaz JL; Fuentes F; de Andrés R; Zambón D; Galiana J; Piedecausa M; Aguado R; Mosquera D; Vidal JI; Ruiz E; Manjón L; Mauri M; Padró T; Miramontes JP; Mata P;
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2004-10. PubMed ID: 27444203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
